SCHEMBL8848741

SCHEMBL8848741

CC(C)(C)C(=O)Oc1ccc(-c2nnn(CCc3ccccc3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.52
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LTA4H P09960 3/20 0.48
TP53 P04637 1/20 0.47
ELANE P08246 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8848912 0.90 LTA4H (0.54) NPC1RAB9AL3MBTL1LTA4HTP53
SCHEMBL8848722 0.88 RAB9A (0.65) MAOBNPC1RAB9AL3MBTL1LTA4H
SCHEMBL8848575 0.84 MAOB (0.54) MAOBNPC1RAB9ALTA4H
SCHEMBL8848799 0.84 LTA4H (0.50) MAOBNPC1RAB9AL3MBTL1LTA4H
SCHEMBL8848642 0.84 HSD17B10 (0.52) NPC1RAB9AL3MBTL1LTA4HTP53
SCHEMBL8848714 0.83 HSD17B10 (0.51) NPC1RAB9AL3MBTL1LTA4HTP53
Hydrochloric Acid SCHEMBL8848858 0.82 LTA4H (0.62) NPC1RAB9ALTA4HELANECYP2C9
SCHEMBL8848788 0.82 MEN1 (0.64) NPC1RAB9AL3MBTL1LTA4HTP53
SCHEMBL8848534 0.82 LTA4H (0.60) NPC1RAB9AL3MBTL1LTA4HTP53
SCHEMBL8848588 0.81 LTA4H (0.48) MAOBNPC1RAB9AL3MBTL1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602161-A ELASTASE INHIBITORS; PREVENTING AND TREATING EMPHYSEMA, ENDOTOXIN-INDUCED LUNG DISORDERS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1997-02-11 US disclosed
EP-0676396-A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component Wakamoto Pharmaceutical Co., Ltd. (JP) 1995-10-11 EP disclosed